Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

NTLA

Intellia Therapeutics, Inc.

Healthcare · USD

Set alert

Price alert · NTLA

All alert types
12.47 USD -0.76 -5.74%
As of Oct 30, 2026 Extended hours 12.35 -0.96%
Bid
12.46 × 2
Ask
12.47 × 2
12.04 Day range 13.13
8.04 52-week range 17.84
YTD
+38.71%
1 year
+1.63%
Open
12.82
Prev close
13.23
Mkt cap
1.75B
Vol
4.09M
Avg vol
4.36M
EPS
-3.35
P/E
0.00
Div yield
0.00%
More statistics
Low
12.04
High
13.13
Forward P/E
-4.86
Beta
1.80
Short ratio
7.63
Inst. own
100.56%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
12.23
200-d avg
13.08
1y target
23.11

5D chart

Chart tools
Interval
1m5m15m30m
NTLA five-day price chart11.111.812.513.213.9Oct 26Oct 27Oct 28Oct 29Oct 30

Financial health

Altman Z-Score

2.69 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 2

Valuation

P/E -2.4×
FY 2016: -14.4×FY 2017: -10.2×FY 2018: -6.9×FY 2019: -7.5×FY 2020: -22.7×FY 2021: -31.3×FY 2022: -5.7×FY 2023: -5.6×FY 2024: -2.2×FY 2025: -2.4×
FY 2016 5y median -5.6× FY 2025
P/S 14.4×
FY 2016: 27.5×FY 2017: 26.5×FY 2018: 19.3×FY 2019: 16.1×FY 2020: 52.5×FY 2021: 254×FY 2022: 51.5×FY 2023: 74.6×FY 2024: 19.9×FY 2025: 14.4×
FY 2016 5y median 51.5× FY 2025
P/B 1.5×
FY 2016: 2.2×FY 2017: 2.3×FY 2018: 2.1×FY 2019: 2.6×FY 2020: 5.8×FY 2021: 8.1×FY 2022: 2.2×FY 2023: 2.6×FY 2024: 1.3×FY 2025: 1.5×
FY 2016 5y median 2.2× FY 2025
P/FCF -2.7×
FY 2016: 15.2×FY 2017: -9.2×FY 2018: -8.7×FY 2019: -6.3×FY 2020: -56.9×FY 2021: -35.3×FY 2022: -6.9×FY 2023: -6.6×FY 2024: -3.2×FY 2025: -2.7×
FY 2016 5y median -6.6× FY 2025
EV/EBITDA -2.3×
FY 2016: -5.8×FY 2017: -5.3×FY 2018: -6.1×FY 2019: -6.5×FY 2020: -22.5×FY 2021: -31.9×FY 2022: -4.9×FY 2023: -5.5×FY 2024: -2.3×FY 2025: -2.3×
FY 2016 5y median -4.9× FY 2025
EV/Sales 13.5×
FY 2016: 11.0×FY 2017: 13.5×FY 2018: 17.4×FY 2019: 15.2×FY 2020: 50.4×FY 2021: 252×FY 2022: 44.0×FY 2023: 71.5×FY 2024: 20.3×FY 2025: 13.5×
FY 2016 5y median 44.0× FY 2025
FCF Yield -36.4%
FY 2016: 6.6%FY 2017: -10.9%FY 2018: -11.5%FY 2019: -15.9%FY 2020: -1.8%FY 2021: -2.8%FY 2022: -14.6%FY 2023: -15.1%FY 2024: -30.8%FY 2025: -36.4%
FY 2016 5y median -15.1% FY 2025

Profitability

Gross Margin 76.5%
FY 2016: -93.2%FY 2017: -159.0%FY 2018: -192.8%FY 2019: -151.5%FY 2020: -159.4%FY 2021: 79.2%FY 2022: 85.5%FY 2023: 75.3%FY 2024: 82.2%FY 2025: 76.5%
FY 2016 5y median 79.2% FY 2025
Operating Margin -651.7%
FY 2016: -195.2%FY 2017: -266.3%FY 2018: -298.6%FY 2019: -246.8%FY 2020: -235.5%FY 2021: -810.4%FY 2022: -879.0%FY 2023: -1420.5%FY 2024: -923.1%FY 2025: -651.7%
FY 2016 5y median -879.0% FY 2025
Net Margin -609.9%
FY 2016: -192.0%FY 2017: -258.6%FY 2018: -280.4%FY 2019: -230.9%FY 2020: -231.5%FY 2021: -810.5%FY 2022: -909.8%FY 2023: -1326.5%FY 2024: -896.8%FY 2025: -609.9%
FY 2016 5y median -896.8% FY 2025
ROE -61.5%
FY 2016: -15.1%FY 2017: -22.5%FY 2018: -30.7%FY 2019: -36.9%FY 2020: -25.5%FY 2021: -25.8%FY 2022: -38.4%FY 2023: -45.8%FY 2024: -59.5%FY 2025: -61.5%
FY 2016 5y median -45.8% FY 2025
ROIC -57.7%
FY 2016: -12.0%FY 2017: -20.2%FY 2018: -29.6%FY 2019: -34.9%FY 2020: -22.1%FY 2021: -22.7%FY 2022: -32.5%FY 2023: -42.8%FY 2024: -48.6%FY 2025: -57.7%
FY 2016 5y median -42.8% FY 2025
ROA -49.0%
FY 2016: -10.6%FY 2017: -18.0%FY 2018: -24.6%FY 2019: -29.8%FY 2020: -19.8%FY 2021: -20.7%FY 2022: -31.2%FY 2023: -37.0%FY 2024: -43.6%FY 2025: -49.0%
FY 2016 5y median -37.0% FY 2025

Growth (YoY)

Revenue 16.9%
FY 2016: 172.7%FY 2017: 58.5%FY 2018: 16.5%FY 2019: 41.6%FY 2020: 34.5%FY 2021: -43.0%FY 2022: 57.7%FY 2023: -30.4%FY 2024: 59.6%FY 2025: 16.9%
FY 2016 FY 2025
Operating Income 17.5%
FY 2016: -139.8%FY 2017: -116.3%FY 2018: -30.6%FY 2019: -17.1%FY 2020: -28.4%FY 2021: -96.1%FY 2022: -71.1%FY 2023: -12.5%FY 2024: -3.7%FY 2025: 17.5%
FY 2016 FY 2025
EPS (diluted) 27.4%
FY 2016: -30.0%FY 2017: -106.6%FY 2018: -5.3%FY 2019: 1.0%FY 2020: -22.4%FY 2021: -57.5%FY 2022: -63.0%FY 2023: 12.0%FY 2024: 3.1%FY 2025: 27.4%
FY 2016 FY 2025
Free Cash Flow 0.0%
FY 2016: 793.6%FY 2017: -351.7%FY 2018: 10.3%FY 2019: -62.7%FY 2020: 51.4%FY 2021: -344.5%FY 2022: -64.7%FY 2023: -4.2%FY 2024: 13.1%FY 2025: 0.0%
FY 2016 FY 2025

Financial Health

Current Ratio 5.1×
FY 2016: 9.2×FY 2017: 11.3×FY 2018: 8.0×FY 2019: 8.1×FY 2020: 9.6×FY 2021: 6.1×FY 2022: 9.6×FY 2023: 8.7×FY 2024: 5.8×FY 2025: 5.1×
FY 2016 5y median 6.1× FY 2025
Quick Ratio 5.1×
FY 2016: 9.2×FY 2017: 11.3×FY 2018: 8.0×FY 2019: 8.1×FY 2020: 9.6×FY 2021: 6.1×FY 2022: 9.6×FY 2023: 8.7×FY 2024: 5.8×FY 2025: 5.1×
FY 2016 5y median 6.1× FY 2025
Debt / Equity 0.1×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.2×FY 2025: 0.1×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA 0.2×
FY 2016: 8.8×FY 2017: 5.1×FY 2018: 0.7×FY 2019: 0.4×FY 2020: 0.9×FY 2021: 0.2×FY 2022: 0.8×FY 2023: 0.2×FY 2024: -0.0×FY 2025: 0.2×
FY 2016 5y median 0.2× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31